Insights On Trial Design

31. Understanding The FDA's Push For More Representation In Clinical Trials 1/28/2025

    Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.

32. A Patient's Life-Changing Experience With Diabetes Research 7/12/2024

    Discover the inspiring journey of one man who battled diabetes and experienced a transformative shift in his life through a patient-focused clinical trial at the Elligo Clinical Research Center.

33. Critical Imaging Risks In GLP-1 And Neurology Studies 4/3/2025

    In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.

34. Oncolytic Virus Therapy: Global Clinical Trial Landscape (2024) 1/30/2025

    Addressing immunological challenges and navigating the evolving regulatory environment is critical for its successful integration into clinical practice.

35. A Global Overview Of Liver Cancer Clinical Studies 7/3/2024

    This FAQ examines advancements in liver cancer treatment, emphasizing innovative drugs, current clinical trials, and their potential effects on patient outcomes.

36. Endometrial Cancer — Global Clinical Trial Landscape (2024) 5/17/2024

    Enhance your knowledge of the latest advancements in endometrial cancer research with this CRO disease report, featuring new treatments, clinical trials, and future innovations in care.

37. From Crisis To Confidence: Ensuring Smooth Regulatory Submissions 10/8/2024

    Explore some of the major challenges that medical writing submission specialists face today and strategies that can consistently set the stage for success.

38. Enhance Access And Improve Retention In Rare Disease Trials With HTS 4/17/2025

    Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.

39. Enhancing The Biosimilar Review Process 8/12/2025

    The biosimilar market is projected to reach over $100 billion in the next five years. Learn how to navigate the expanding landscape and overcome challenges in accessing key clinical information.

40. Retention Isn't A Reminder Problem: How PXO Reduces Dropout 8/5/2025

    Learn about a Patient Experience Optimization (PXO) model employing four strategic layers to predict and prevent patient dropout by aligning patient needs with real-time operational support.